- Home
- ARWR vs BRX Comparison
ARWR vs BRX Comparison
Compare ARWR & BRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | BRX |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.2B |
| IPO Year | 1993 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ARWR | BRX |
|---|---|---|
| Price | $67.81 | $26.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $73.70 | $29.91 |
| AVG Volume (30 Days) | 2.6M | ★ 2.7M |
| Earning Date | 02-05-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 4.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.08 |
| Revenue | $829,448,000.00 | ★ $1,346,289,000.00 |
| Revenue This Year | N/A | $7.62 |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | ★ N/A | $24.69 |
| Revenue Growth | ★ 23258.15 | 5.75 |
| 52 Week Low | $9.57 | $22.29 |
| 52 Week High | $76.76 | $28.61 |
Technical Indicators
Market Signals| Indicator | ARWR | BRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 58.12 |
| Support Level | $61.65 | $25.46 |
| Resistance Level | $68.24 | $26.34 |
| Average True Range (ATR) | 3.79 | 0.46 |
| MACD | -0.69 | 0.08 |
| Stochastic Oscillator | 45.29 | 76.87 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.